Decitabine.
Gore
Steven D
SD
Jones
Carole
C
Kirkpatrick
Peter
P
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001374:Azacitidine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D019175:DNA Methylation / Q000187:drug effects; D000077209:Decitabine; D017277:Drug Approval; D006801:Humans; D009190:Myelodysplastic Syndromes / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D000964:Antimetabolites, Antineoplastic; D000077209:Decitabine; D001374:Azacitidine